Back to all Programs

Register here

Related Materials

Past event

Gulf HIV Clinical Forum 2019

Integrase Inhibitor Resistance: Does it Matter? - Charles Boucher, MD, PhD

Antiretroviral Therapy in Pregnancy: Risks and Benefits - Sanjay Bhagani, BSc, FRCP

Novel Treatment Options - Long Acting Antiretroviral Compounds - Andrea Calcagno, MD, DTM&H

Reducing HIV Stigma and Promoting Early Diagnosis - Bandar Alamri, MD

Switching ARV Therapy - Clinical and Resistance Considerations - Roger Paredes, MD, PhD

ARV Toxicity and Their Management (Including Weight Gain) - Laura Waters, MD

Switching ARV Therapy - Clinical and Pharmacological Considerations - Andrea Calcagno, MD, DTM&H

Attributes of INSTIs as a First Line Treatment Option - Sanjay Bhagani, BSc, FRCP

Two Versus Three Drugs - What are the Data? - Roger Paredes, MD, PhD

Optimal Use of INSTIs in KSA - Ghassan Wali, MD, FRCP(C)